Guidance for Market Authorization Holders on Post-Marketing Safety Reporting for Human Drugs,Narcotics, and Medicinal Neuropsychotropic Substances
“
Guidance for Market Authorization Holders on Post-Marketing Safety Reporting for Human Drugs,Narcotics, and Medicinal Neuropsychotropic Substances
“